03759.HK
Pharmaron Beijing Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 29.00
−2.03%Margins
Gross margin
33.5%
EBITDA margin
17.1%
EBIT margin
13.9%
Net margin
11.3%
FCF margin
0.3%
10.4%
Return on equity
5.9%
Return on assets
9.0%
Return on invested capital
0.52x
Asset turnover
HKD 3.4B
Cash from operations
HKD 1.59
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026